Healthcare & Life Sciences
Dren Bio
United Statesdrenbio.com
Dren Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
2019
Founded
1
Investors
About Dren Bio
Based in the United States, Dren Bio is a startup founded in 2019. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics that selectively target and deplete pathogenic cells for the treatment of cancer and autoimmune diseases.
Explore Dren Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.